FCMV

Foresite Capital Management V Portfolio holdings

AUM $80.7M
This Quarter Return
+28.21%
1 Year Return
-24.46%
3 Year Return
+66.81%
5 Year Return
10 Year Return
AUM
$135M
AUM Growth
Cap. Flow
+$135M
Cap. Flow %
100%
Top 10 Hldgs %
98.63%
Holding
12
New
12
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 82.37%
2 Consumer Staples 9.42%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
KNTE
1
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$34.8M 25.78% +875,001 New +$34.8M
ALXO icon
2
ALX Oncology
ALXO
$62.7M
$27.6M 20.43% +320,000 New +$27.6M
RLAY icon
3
Relay Therapeutics
RLAY
$619M
$16.6M 12.31% +400,000 New +$16.6M
NRIX icon
4
Nurix Therapeutics
NRIX
$714M
$14.8M 10.99% +451,522 New +$14.8M
HIMS icon
5
Hims & Hers Health
HIMS
$9.57B
$12.7M 9.42% +871,422 New +$12.7M
PHICU
6
DELISTED
Population Health Investment Co., Inc. Unit
PHICU
$10M 7.43% +960,000 New +$10M
PNT
7
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$4.87M 3.61% +350,000 New +$4.87M
TNGX icon
8
Tango Therapeutics
TNGX
$747M
$4.58M 3.39% +400,000 New +$4.58M
SNCE
9
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$4.27M 3.16% +400,000 New +$4.27M
MLTX icon
10
MoonLake Immunotherapeutics
MLTX
$3.54B
$2.84M 2.11% +250,000 New +$2.84M
ABCL icon
11
AbCellera Biologics
ABCL
$1.25B
$805K 0.6% +20,000 New +$805K